Mark Lappe

Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX.

Osmetech Ltd. designs, develops, manufactures and sells molecular diagnostics instruments and consumables enabling deoxyribonucleic acid, ribonucleic acid and protein testing. Its operates in Atlanta, Boston and Pasadena in the US, serving the growth, near patient testing market targeting small to medium sized hospitals. Osmetech was founded in 1993 and is headquartered in London, the United Kingdom.

Founded in 2004 by Mark Paul Lappe and Jon Faiz Kayyem, Efficacy Capital LLC is a hedge fund manager located in La Jolla, California. The firm provides investment management services primarily to high net-worth individuals. They also manage pooled investment vehicles, including hedge funds and mutual funds

Inhibrx LP developed therapeutic antibodies and pharmaceuticals. Its programs focused on oncology, inflammatory and metabolic diseases and these programs are based on an implementation of multiple antibody and biologic development strategies for therapeutic lead generation, selection, functional enhancement, and optimization. The firm's platforms enabled fit-for-function biotherapeutics that interface with the biology of each target antigen, focus immune activation, and mediate enhanced signaling. The company was founded by Quinn Deveraux, Brendan Eckelman, and Mark Paul Lappe in 2010 and was headquartered in La Jolla, CA.